These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 3013773)

  • 1. Significance of the vascular renin-angiotensin pathway.
    Dzau VJ
    Hypertension; 1986 Jul; 8(7):553-9. PubMed ID: 3013773
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension: relationships between pathophysiology and therapy.
    Bailie MD; Mattioli LF
    J Pediatr; 1980 May; 96(5):789-97. PubMed ID: 6102595
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between the circulating and vascular renin-angiotensin system and the vasodilating effect of captopril in human hypertension.
    Virdis A; Ghiadoni L; Favilla S; Duranti P; Taddei S; Salvetti A
    Blood Press; 1999; 8(2):85-93. PubMed ID: 10451035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of the renin-angiotensin system: a major breakthrough in the treatment of arterial hypertension?].
    Menard J; Corvol P
    Nouv Presse Med; 1980 Feb; 9(9):579-83. PubMed ID: 6244532
    [No Abstract]   [Full Text] [Related]  

  • 5. Captopril versus enalapril: a comparison of 24 h humoral and hypotensive effects.
    Cottone S; Grasso L; D'Ignoto G; Contorno A; Ziletti T; Carapelle E; Carone MB; Fulantelli MA; Cerasola G
    Boll Soc Ital Biol Sper; 1987 Sep; 63(9):803-10. PubMed ID: 2833914
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular renin-angiotensin system and neurotransmission in hypertensive persons.
    Taddei S; Favilla S; Duranti P; Simonini N; Salvetti A
    Hypertension; 1991 Sep; 18(3):266-77. PubMed ID: 1653766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
    Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
    Cody RJ
    Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renovascular hypertension. Concepts and reality].
    Ménard J; Corvol P; Plouin PF; Lagneau P
    Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():5-8. PubMed ID: 43713
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the renin-angiotensin system in blood pressure regulation in normotensive animals and man.
    Corvol P; Michel JB; Evin G; Gardes J; Bensala-Alaoui A; Ménard J
    J Hypertens Suppl; 1984 Dec; 2(2):S25-30. PubMed ID: 6100873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
    Atlas SA; Niarchos AP; Case DB
    Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK; Williams GH
    Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renin-angiotensin system inhibitors - biochemical and clinical aspects].
    Kuska J; Germakowska-Kowalik T; Pluta S
    Postepy Hig Med Dosw; 1982; 35(4):395-411. PubMed ID: 6183653
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs affecting the renin-angiotensin system.
    Ashworth RW
    Prog Drug Res; 1982; 26():207-23. PubMed ID: 6183711
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of aging on the renin angiotensin system in patients with renovascular hypertension.
    Morishita R; Higaki J; Mikami H; Matsukawa N; Ogihara T
    Methods Find Exp Clin Pharmacol; 1992; 14(1):17-21. PubMed ID: 1619967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats.
    Higashimori K; Nakamaru M; Tabuchi Y; Nagano M; Mikami H; Ogihara T; Inagami T
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):56S-59S. PubMed ID: 2009150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of chronic enalapril treatment on prorenin, renin and sex hormones during the menstrual cycle in patients with essential hypertension].
    Troffa C; Tonolo G; Manunta P; Pinna Parpaglia P; Madeddu P; Melis MG; Soro A; Pala F; Pazzola A; Patteri G
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):663-70. PubMed ID: 2083060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The renin-angiotensin system. Physiopathological aspects and clinical implications of hypertensive syndromes. A survey].
    Molinatti GM; Limone P
    Minerva Med; 1981 Mar; 72(12):715-32. PubMed ID: 6164019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular angiotensin pathways: a new therapeutic target.
    Dzau VJ
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S9-16. PubMed ID: 2485070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Components of the renin system. An update.
    Hsueh WA
    Am J Nephrol; 1983; 3(2-3):109-17. PubMed ID: 6346872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.